Journal article

Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2

A Reghan Foley, Manoj P Menezes, Amelie Pandraud, Michael A Gonzalez, Ahmad Al-Odaib, Alexander J Abrams, Kumiko Sugano, Atsushi Yonezawa, Adnan Y Manzur, Joshua Burns, Imelda Hughes, B Gary McCullagh, Heinz Jungbluth, Ming J Lim, Jean-Pierre Lin, Andre Megarbane, J Andoni Urtizberea, Ayaz H Shah, Jayne Antony, Richard Webster Show all

BRAIN | OXFORD UNIV PRESS | Published : 2014


Awarded by National Institutes of Health

Awarded by Medical Research Council: MRC

Awarded by MRC neuromuscular centre

Awarded by Ministry of Education, Science, Culture and Sports of Japan

Awarded by Medical Research Council

Awarded by Rosetrees Trust

Awarded by Great Ormond Street Hospital Childrens Charity

Awarded by Muscular Dystrophy UK

Awarded by Grants-in-Aid for Scientific Research


Funding Acknowledgements

This work was supported by grants from the National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre; the National Institutes of Health [R01NS075764-01A1 (S.Z.), R01NS072248 (S.Z.), U54NS065712 (J.B., M. M. R. and S.Z.)]; the Medical Research Council: MRC fellowship G0802760 (H. H.) and MRC neuromuscular centre grant G0601943; the Wellcome Trust; a grant-in-aid for Scientific Research (KAKENHI) from the Ministry of Education, Science, Culture and Sports of Japan [24590190 (A.Y.), 24590176 (K. M.) and 25136710 (K. M.)]; the Muscular Dystrophy Campaign (A. R. F.), the Thyne Reid Foundation (M. P. M.) and the Great Ormond Street Hospital Children's Charity (F. M., P. C. and S.R.).